Repligen raising $100m may signal more M&A activity to come
An offering of $100m of convertible notes expected to close today could be used to fund future acquisitions, according to Repligen.
Archives for May 23, 2016
Combination therapies key to curing cancer, says Pfizer
Combination therapies and collaboration will be key in curing cancer, according to Pfizer which has seen 'astounding progress' in its immuno-oncology partnership with Merck KGaA.
US FDA accepts Samsung Bioepis' Remicade biosimilar for review
The US FDA has accepted Samsung Bioepis’ infliximab biosimilar – known as SB2 - for review.